Leishmania major self-limited infection increases blood cholesterol and promotes atherosclerosis development

Cholesterol

Volumn 2013, Issue , 2013, Pages

  Fernandes, Luciana R ^a   Ribeiro, Ana Cecília C ^a   Segatto, Marcela ^a   Santos, Luís Felipe F F ^a   Amaral, Joana ^b   Portugal, Luciane R ^a   Leite, Jacqueline I A ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Fundação Instituto de Ensino para Osasco UNIFIEO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CD36 ANTIGEN; CHOLESTEROL; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; AORTA VALVE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; INFLAMMATION; INFLAMMATORY INFILTRATE; LEISHMANIA MAJOR; LEISHMANIASIS; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 84877994772     PISSN: 20901283     EISSN: 20901291     Source Type: Journal    
DOI: 10.1155/2013/754580     Document Type: Article

References (33)

1. Liese J., Schleicher U., Bogdan C., The innate immune response against Leishmania parasites. Immunobiology 2008 213 3-4 377 387 2-s2.0-41649111868 10.1016/j.imbio.2007.12.005
2. Hansson G. K., Inflammatory mechanisms in atherosclerosis. Journal of Thrombosis and Haemostasis 2009 7 1 328 331 2-s2.0-67849088725 10.1111/j.1538-7836.2009.03416.x
3. Ross R., Atherosclerosis-an inflammatory disease. The New England Journal of Medicine 1999 340 2 115 126 2-s2.0-0033552883 10.1056/NEJM199901143400207 (Pubitemid 29054847)
4. Hansson G. K., Libby P., The immune response in atherosclerosis: a double-edged sword. Nature Reviews Immunology 2006 6 7 508 519 2-s2.0-33745571976 10.1038/nri1882 (Pubitemid 43980523)
5. Kiechl S., Egger G., Mayr M., Wiedermann C. J., Bonora E., Oberhollenzer F., Muggeo M., Xu Q., Wick G., Poewe W., Willeit J., Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation 2001 103 8 1064 1070 2-s2.0-0035957027 (Pubitemid 32200178)
6. Noll G., Pathogenesis of atherosclerosis: a possible relation to infection. Atherosclerosis 1998 140 1 S3 S9 2-s2.0-0031788882 10.1016/S0021-9150(98)00113-0 (Pubitemid 28535484)
7. Mussa F. F., Chai H., Wang X., Yao Q., Lumsden A. B., Chen C., Chlamydia pneumoniae and vascular disease: an update. Journal of Vascular Surgery 2006 43 6 1301 1307 2-s2.0-33744737249 10.1016/j.jvs.2006.02.050 (Pubitemid 43825695)
8. Murray L. J., Bamford K. B., O'Reilly D. P. J., McCrum E. E., Evans A. E., Helicobacter pylori infection: relation with cardiovascular risk factors, ischaemic heart disease, and social class. British Heart Journal 1995 74 5 497 501 2-s2.0-0028804158
9. Burnett M. S., Durrani S., Stabile E., Saji M., Lee C. W., Kinnaird T. D., Hoffman E. P., Epstein S. E., Murine cytomegalovirus infection increases aortic expression of proatherosclerotic genes. Circulation 2004 109 7 893 897 2-s2.0-1342331002 10.1161/01.CIR.0000112585.47513.45 (Pubitemid 38252742)
10. Doenhoff M. J., Stanley R. G., Griffiths K., Jackson C. L., An anti-atherogenic effect of Schistosoma mansoni infections in mice associated with a parasite-induced lowering of blood total cholesterol. Parasitology 2002 125 5 415 421 2-s2.0-0036856173 10.1017/S0031182002002275 (Pubitemid 35397378)
11. Portugal L. R., Fernandes L. R., Cesar G. C., Santiago H. C., Oliveira D. R., Silva N. M., Silva A. A., Lannes-Vieira J., Arantes R. M. E., Gazzinelli R. T., Alvarez-Leite J. I., Infection with Toxoplasma gondii increases atherosclerotic lesion in ApoE-deficient mice. Infection and Immunity 2004 72 6 3571 3576 2-s2.0-2542606939 10.1128/IAI.72.6.3571-3576.2004 (Pubitemid 38697785)
12. Meurman J. H., Sanz M., Janket S. J., Oral health, atherosclerosis, and cardiovascular disease. Critical Reviews in Oral Biology and Medicine 2004 15 6 403 413 2-s2.0-25844476021 10.1177/154411130401500606 (Pubitemid 44567524)
13. Zhang H., Wu L. M., Wu J., Cross-talk between apolipoprotein E and cytokines. Mediators of Inflammation 2011 2011 10 949072 10.1155/2011/949072
14. Capettini L. S., Cortes S. F., Silva J. F., Alvarez-Leite J. I., Lemos V. S., Decreased production of nNOS-derived hydrogen peroxide contributes to endothelial dysfunction in atherosclerosis. British Journal of Pharmacology 2011 164 6 1738 1748 10.1111/j.1476-5381.2011.01500.x
15. Reeves P. G., Nielsen F. H., Fahey G. C., AIN-93 purified diets for laboratory rodents: final report of the american institute of nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. The Journal of Nutrition 1993 123 11 1939 1951 2-s2.0-0027487229 (Pubitemid 23342492)
16. Vieira L. Q., Goldschmidt M., Nashleanas M., Pfeffer K., Mak T., Scott P., Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication. The Journal of Immunology 1996 157 2 827 835 2-s2.0-0029982872 (Pubitemid 26231389)
17. Fazio S., Babaev V. R., Murray A. B., Hasty A. H., Carter K. J., Gleaves L. A., Atkinson J. B., Linton M. F., Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages. Proceedings of the National Academy of Sciences of the United States of America 1997 94 9 4647 4652 2-s2.0-0030945298 10.1073/pnas.94.9.4647 (Pubitemid 27194297)
18. Folch J., Lees M., Sloane S. G. H., A simple method for the isolation and purification of total lipides from animal tissues. The Journal of biological chemistry 1957 226 1 497 509 2-s2.0-70449158340
19. Paigen B., Morrow A., Holmes P. A., Mitchell D., Williams R. A., Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis 1987 68 3 231 240 2-s2.0-0023634643 (Pubitemid 17159775)
20. Anders G., Eisenberger C. L., Jonas F., Greenblatt C. L., Distinguishing Leishmania tropica and Leishmania major in the Middle East using the polymerase chain reaction with kinetoplast DNA-specific primers. Transactions of the Royal Society of Tropical Medicine and Hygiene 2002 96 supplement 1 S87 S92 2-s2.0-16744366071
21. Shamshiev A. T., Ampenberger F., Ernst B., Rohrer L., Marsland B. J., Kopf M., Dyslipidemia inhibits Toll-like receptor-induced activation of CD8 α -negative dendritic cells and protective Th1 type immunity. Journal of Experimental Medicine 2007 204 2 441 452 2-s2.0-33847128883 10.1084/jem.20061737 (Pubitemid 46294558)
22. Santiago H. C., Oliveira C. F., Santiago L., Ferraz F. O., De Souza D. G., De-Freitas L. A., Afonso L. C., Teixeira M. M., Tostes Gazzinelli R., Vieira L. Q., Involvement of the chemokine RANTES (CCL5) in resistance to experimental infection with Leishmania major. Infection and Immunity 2004 72 8 4918 4923 2-s2.0-3342971008 10.1128/IAI.72.8.4918-4923.2004 (Pubitemid 38989359)
23. Oliveira C. F., Manzoni-de-Almeida D., Mello P. S., Natale C. C., Santiago H. C., Miranda L. S., Ferraz F. O., dos Santos L. M., Teixeira M. M., Arantes R. M., Characterization of chronic cutaneous lesions from TNF-receptor-1-deficient mice infected by Leishmania major. Clinical and Developmental Immunology 2012 2012 12 865708 10.1155/2012/865708
24. Benhnini F., Chenik M., Laouini D., Louzir H., Cazenave P. A., Dellagi K., Comparative evaluation of two vaccine candidates against experimental leishmaniasis due to Leishmania major infection in four inbred mouse strains. Clinical and Vaccine Immunology 2009 16 11 1529 1537 2-s2.0-70350712424 10.1128/CVI.00153-09
25. Sacks D., Noben-Trauth N., The immunology of susceptibility and resistance to Leishmania major in mice. Nature Reviews Immunology 2002 2 11 845 858 2-s2.0-0036831673 10.1038/nri933 (Pubitemid 37328707)
26. Zhou X., Paulsson G., Stemme S., Hansson G. K., Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice. Journal of Clinical Investigation 1998 101 8 1717 1725 2-s2.0-0032522995 (Pubitemid 28198502)
27. Jansen G. R., Zanetti M. E., Hutchison C. F., Stdies on lipogenesis in vivo. Effects of starvation andre-feeding, and studies on cholesterol synthesis. Biochemical Journal 1966 99 2 333 340 2-s2.0-0013908224
28. Ginger M. L., Prescott M. C., Reynolds D. G., Chance M. L., Goad J. L., Utilization of leucine and acetate as carbon sources for sterol and fatty acid biosynthesis by old and new world Leishmania species, Endotrypanum monterogeii and Trypanosoma cruzi. European Journal of Biochemistry 2000 267 9 2555 2566 2-s2.0-0034111424 10.1046/j.1432-1327.2000.01261.x (Pubitemid 30304250)
29. Hart D. T., Coombs G. H., Leishmania mexicana: energy metabolism of amastigotes and promastigotes. Experimental Parasitology 1982 54 3 397 409 2-s2.0-0020353207 (Pubitemid 13149794)
30. Rizzo M., Berneis K., Low-density lipoprotein size and cardiovascular risk assessment. QJM 2006 99 1 1 14 2-s2.0-31144439939 10.1093/qjmed/hci154 (Pubitemid 43124966)
31. Esteve E., Ricart W., Fernández-Real J. M., Dyslipidemia and inflammation: an evolutionary conserved mechanism. Clinical Nutrition 2005 24 1 16 31 2-s2.0-12744263365 10.1016/j.clnu.2004.08.004
32. Nieto C. G., Barrera R., Habela M. A., Navarrete I., Molina C., Jimenez A., Serrera J. L., Changes in the plasma concentrations of lipids and lipoprotein fractions in dogs infected with Leishmania infantum. Veterinary Parasitology 1992 44 3-4 175 182 2-s2.0-0026497614 10.1016/0304-4017(92)90115-P
33. Hansson G. K., Inflammation, atherosclerosis, and coronary artery disease. The New England Journal of Medicine 2005 352 16 1685 1626 2-s2.0-17644412023 10.1056/NEJMra043430 (Pubitemid 40530235)